Literature DB >> 2422208

Differential effect of cyclosporin A on activation signaling in human T cell lines.

B Manger, K J Hardy, A Weiss, J D Stobo.   

Abstract

Different T cell lines, which can be induced to secrete interleukin 2 (IL-2) in vitro, were used to dissect the effect of cyclosporin A (CsA). The T leukemia cell Jurkat requires an increase in cytoplasmic calcium concentration ([Ca++]i) and phorbol myristate acetate (PMA) for the induction of IL-2 production, which is completely blocked by CsA. Another T cell line, HUT 78, also produces IL-2 in response to a rise in [Ca++]i and PMA; however, in HUT 78, PMA alone induces low levels of IL-2 production that is not blocked by CsA. After treatment with 5-azacytidine, HUT 78 cells produced maximal levels of IL-2 in response to PMA alone without requiring [Ca++]i increasing stimuli. In these cells no inhibitory effect of CsA on PMA-induced activation could be demonstrated. In addition, CsA does not inhibit PMA-induced translocation of protein kinase C. These data suggest that CsA does not globally inhibit IL-2 gene expression, but rather interferes with signaling events of T cell activation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2422208      PMCID: PMC424552          DOI: 10.1172/JCI112464

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  30 in total

Review 1.  Cyclosporin A--usefulness, risks and mechanism of action.

Authors:  S Britton; R Palacios
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

2.  Cyclosporin A and dexamethasone suppress T cell responses by selectively acting at distinct sites of the triggering process.

Authors:  E L Larsson
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

3.  Expression of HLA-DR by a human monocyte cell line is under transcriptional control.

Authors:  B M Peterlin; T A Gonwa; J D Stobo
Journal:  J Mol Cell Immunol       Date:  1984

4.  Decrease in cytosolic calcium/phospholipid-dependent protein kinase activity following phorbol ester treatment of EL4 thymoma cells.

Authors:  A S Kraft; W B Anderson; H L Cooper; J J Sando
Journal:  J Biol Chem       Date:  1982-11-25       Impact factor: 5.157

5.  Effects of the new anti-lymphocytic peptide cyclosporin A in animals.

Authors:  J F Borel; C Feurer; C Magnée; H Stähelin
Journal:  Immunology       Date:  1977-06       Impact factor: 7.397

6.  Phorbol esters increase the amount of Ca2+, phospholipid-dependent protein kinase associated with plasma membrane.

Authors:  A S Kraft; W B Anderson
Journal:  Nature       Date:  1983 Feb 17-23       Impact factor: 49.962

7.  DNA methylation controls the inducibility of the mouse metallothionein-I gene lymphoid cells.

Authors:  S J Compere; R D Palmiter
Journal:  Cell       Date:  1981-07       Impact factor: 41.582

8.  Thymoma production of T cell growth factor (Interleukin 2).

Authors:  J J Farrar; J Fuller-Farrar; P L Simon; M L Hilfiker; B M Stadler; W L Farrar
Journal:  J Immunol       Date:  1980-12       Impact factor: 5.422

9.  Effect of cyclosporin A on human lymphocyte responses in vitro. IV. Production of T cell stimulatory growth factors and development of responsiveness to these growth factors in CsA-treated primary MLR cultures.

Authors:  A D Hess; P J Tutschka; Z Pu; G W Santos
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

10.  Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2.

Authors:  D Bunjes; C Hardt; M Röllinghoff; H Wagner
Journal:  Eur J Immunol       Date:  1981-08       Impact factor: 5.532

View more
  9 in total

Review 1.  Structure and function of the T cell antigen receptor.

Authors:  A Weiss
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

2.  Synergism between AS101 and PMA in lymphokine production.

Authors:  B Sredni; Y Kalechman; F Shalit; M Albeck
Journal:  Immunology       Date:  1990-01       Impact factor: 7.397

3.  Silicon photonic microring resonators for quantitative cytokine detection and T-cell secretion analysis.

Authors:  Matthew S Luchansky; Ryan C Bailey
Journal:  Anal Chem       Date:  2010-03-01       Impact factor: 6.986

4.  A screening assay to identify agents that enhance T-cell recognition of human melanomas.

Authors:  Timothy J Haggerty; Ian S Dunn; Lenora B Rose; Estelle E Newton; James T Kurnick
Journal:  Assay Drug Dev Technol       Date:  2011-11-15       Impact factor: 1.738

5.  Phorbol myristate acetate induces IL-2 secretion by HUT 78 cells by a mechanism independent of protein kinase C translocation.

Authors:  D Kelleher; S J Pandol; M F Kagnoff
Journal:  Immunology       Date:  1988-11       Impact factor: 7.397

6.  Multiple phosphorylation events control mitotic degradation of the muscle transcription factor Myf5.

Authors:  Christine Doucet; Gustavo J Gutierrez; Catherine Lindon; Thierry Lorca; Gwendaline Lledo; Christian Pinset; Olivier Coux
Journal:  BMC Biochem       Date:  2005-12-01       Impact factor: 4.059

7.  Corticosteroid delivery using oral mucosa equivalents for the treatment of inflammatory mucosal diseases.

Authors:  Zulfahmi Said; Craig Murdoch; Jens Hansen; Lars Siim Madsen; Helen E Colley
Journal:  Eur J Oral Sci       Date:  2021-03-01       Impact factor: 2.612

8.  The injury-induced myokine insulin-like 6 is protective in experimental autoimmune myositis.

Authors:  Ling Zeng; Sonomi Maruyama; Kazuto Nakamura; Jennifer L Parker-Duffen; Ibrahim M Adham; Xuemei Zhong; Han-Kyu Lee; Henry Querfurth; Kenneth Walsh
Journal:  Skelet Muscle       Date:  2014-08-04       Impact factor: 4.912

9.  Anti-inflammatory and antinociceptive effects of the selective cannabinoid CB2 receptor agonist ABK5.

Authors:  Yaliang Tang; Barbara Wolk; Stevie C Britch; Rebecca M Craft; Debra A Kendall
Journal:  J Pharmacol Sci       Date:  2020-12-29       Impact factor: 3.337

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.